NovaBay Pharmaceuticals, Inc. - FORM 10-K - EX-23.2 - CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 - March 10, 2011

Attached files

file filename
10-K - ANNUAL REPORT - NovaBay Pharmaceuticals, Inc.nova_10k-123110.htm
EX-23.1 - CONSENT OF ODENBERG, ULLAKKO, MURANISHI & CO. LLP - NovaBay Pharmaceuticals, Inc.ex23-1.htm
EX-23.2 - CONSENT OF DAVIDSON & CO, LLP - NovaBay Pharmaceuticals, Inc.ex23-2.htm
EX-31.2 - CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - NovaBay Pharmaceuticals, Inc.ex31-2.htm
EX-31.1 - CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - NovaBay Pharmaceuticals, Inc.ex31-1.htm
EX-23.1 - CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 - NovaBay Pharmaceuticals, Inc.ex32-1.htm
EX-10.24 - AMENDMENT NO. 2 TO THE COLLABORATION AND LICENSE AGREEMENT, DATED AS OF DECEMBER 2, 2010, BETWEEN THE COMPANY AND GALDERMA S.A. - NovaBay Pharmaceuticals, Inc.ex10-24.htm
EX-10.25 - AMENDMENT NO. 1 TO THE COLLABORATION AND LICENSE AGREEMENT DATED NOVEMBER 18, 2010 BY AND BETWEEN THE COMPANY AND ALCON MANUFACTURING, LTD. - NovaBay Pharmaceuticals, Inc.ex10-25.htm
Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. §1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the annual report of NovaBay Pharmaceuticals, Inc. (the Company) on Form 10-K for the fiscal year ended December 31, 2010 (the Report), I, Thomas J. Paulson, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: March 8, 2011

/s/  Thomas J. Paulson                          
Thomas J. Paulson
Chief Financial Officer and Treasurer

This Certification is made solely for the purpose of 18 USC Section 1350, subject to the knowledge standard contained therein, and not for any other purpose.



NovaBay Pharmaceuticals, Inc. Reports